Pham Justin H, Giudicessi John R, Tweet Marysia S, Boucher Lauren, Newman D Brian, Geske Jeffrey B
Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, MN, United States.
Department of Cardiovascular Medicine, Mayo Clinic, Rochester MN, United States.
Front Cardiovasc Med. 2023 Apr 27;10:1167256. doi: 10.3389/fcvm.2023.1167256. eCollection 2023.
Hypertrophic cardiomyopathy (HCM) is a heritable cardiomyopathy that is predominantly caused by pathogenic mutations in sarcomeric proteins. Here we report two individuals, a mother and her daughter, both heterozygous carriers of the same HCM-causing mutation in cardiac Troponin T (). Despite sharing an identical pathogenic variant, the two individuals had very different manifestations of the disease. While one patient presented with sudden cardiac death, recurrent tachyarrhythmia, and findings of massive left ventricular hypertrophy, the other patient manifested with extensive abnormal myocardial delayed enhancement despite normal ventricular wall thickness and has remained relatively asymptomatic. Recognition of the marked incomplete penetrance and variable expressivity possible in a single -positive family has potential to guide HCM patient care.
肥厚型心肌病(HCM)是一种遗传性心肌病,主要由肌节蛋白的致病性突变引起。在此,我们报告两名个体,一位母亲和她的女儿,她们都是心脏肌钙蛋白T中同一导致HCM突变的杂合携带者。尽管携带相同的致病变异,但这两名个体的疾病表现却大不相同。一名患者出现心脏性猝死、反复室性心律失常以及大量左心室肥厚的表现,而另一名患者尽管心室壁厚度正常,但有广泛的异常心肌延迟强化,且相对无症状。认识到在单个致病基因阳性家族中可能存在的显著不完全外显率和可变表达性,有助于指导HCM患者的治疗。